Revealing the details of pharmaceutical industry funding of medical education for physicians and patient disease interest groups is not enough. We need to fully understand the conflicts of interest of drug companies, researchers, physicians and patient advocacy groups. A better solution would be to stop this type spending and lower prices to consumers.
I’ve never known what to make of the disclosure of industry funding of a researcher. Should I disregard the findings? How can one have confidence in results when researchers are on the company payroll? What has been omitted, deemphasized or statistically manipulated?
Those with grey hair will recall that the pharmaceutical companies used to call themselves the “ethical” pharmaceutical industry. Their “ethical” has been tarnished and is rarely used today to describe these robber barons.
Powered by Zoundry